| 靶点: |
COX, Reactive oxygen species, MMP |
| 体内研究: |
Significantly inhibited the adipocyte size, the visceral adipocyte tissue weights and the average bodyweights in HFD mice. |
| 参考文献: |
1. Song M, et al. Feprazone Prevents Free Fatty Acid (FFA)-Induced Endothelial Inflammation by Mitigating the Activation of the TLR4/MyD88/NF-κB Pathway. ACS Omega. 2021 Feb 9;6(7):4850-4856. 2. Fletcher MR, et al. Feprazone, a new anti-inflammatory agent. Studies of potency and gastrointestinal tolerance. Ann Rheum Dis. 1975 Apr;34(2):190-4. 3. Che L, et al. Feprazone Displays Antiadipogenesis and Antiobesity Capacities in in Vitro 3 T3-L1 Cells and in Vivo Mice. ACS Omega. 2021 Mar 7;6(10):6674-6680. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.121 ml |
15.606 ml |
31.212 ml |
| 5 mM |
0.624 ml |
3.121 ml |
6.242 ml |
| 10 mM |
0.312 ml |
1.561 ml |
3.121 ml |
| 50 mM |
0.062 ml |
0.312 ml |
0.624 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |